BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sherman KE, Kang M, Sterling R, Umbleja T, Marks K, Kiser JJ, Alston-Smith B, Greaves W, Butt AA, the ACTG 5294 BIRTH Study Team. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World J Hepatol 2017; 9(4): 217-223 [PMID: 28217259 DOI: 10.4254/wjh.v9.i4.217]
URL: https://www.wjgnet.com/1948-5182/full/v9/i4/217.htm
Number Citing Articles
1
Kenneth E. Sherman, Susan D. Rouster, Minhee Kang, Triin Umbleja, Richard Sterling, Adeel A. Butt. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected IndividualsDigestive Diseases and Sciences 2018; 63(11): 2969 doi: 10.1007/s10620-018-5278-y
2
Jennifer J. Kiser, Darlene Lu, Susan L. Rosenkranz, Gene D. Morse, Robin DiFrancesco, Kenneth E. Sherman, Adeel A. Butt. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sDrugs in R&D 2017; 17(4): 557 doi: 10.1007/s40268-017-0205-9
3
Jiali Liu, Minghong Yao, Mingqi Wang, Wan Jie, Yanmei Liu, Xiaochao Luo, Jiayidaer Huan, Kelin Deng, Ke Deng, Kang Zou, Ying Zhang, Ling Li, Xin Sun. Design, Conduct, and Analysis of Externally Controlled TrialsJAMA Network Open 2025; 8(9): e2530277 doi: 10.1001/jamanetworkopen.2025.30277